Hanmi Pharmaceutical., Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanmi Pharmaceutical., Company Limited with three other
companies in this sector in South Korea:
Kwang Dong Pharmaceutical Company Limited
sales of 955.45 billion Korean Won [US$807.36 million]
of which 43%
was Food Product Operations),
Daewoong Pharmaceutical Company Limited
(839.69 billion Korean Won [US$709.54 million]
of which 100%
was Medicine Manufacture&Sale), and
Daewoong Company Limited
(996.65 billion Korean Won [US$842.17 million]
of which 105%
was Medicinal Manufacturing & Selling).
Hanmi Pharmaceutical., Company Limited reported sales of 1.32 trillion Korean Won (US$1.11 billion)
December of 2015.
increase of 73.1%
versus 2014, when the company's sales were 761.28 billion Korean Won.
Sales at Hanmi Pharmaceutical., Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 348%).
Sales of Medicine saw an increase
92.6% in 2015, from
574.02 billion Korean Won to 1.11 trillion Korean Won.
Not all segments of Hanmi Pharmaceutical., Company Limited experienced an increase in sales in 2015:
sales of Raw Medicine fell 51.5% to 7.01 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).